Hepatitis C virus infection in intravenous drug users

被引：17
|
作者：
Harder, J
Walter, E
Riecken, B
Ihling, C
Bauer, TM
机构：
[1] Univ Freiburg, Med Klin, Innere Med Abt 2, Dept Pathol, D-79106 Freiburg, Germany
[2] Univ Freiburg, Univ Hosp, Dept Med Gastroenterol Hepatol & Infect Dis 2, Freiburg, Germany
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 08期
关键词：
drug users; hepatitis C; liver function tests; liver histology;
D O I：
10.1111/j.1469-0691.2004.00934.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Intravenous drug use (IVDU) remains a major means of hepatitis C virus (HCV) transmission. In this study, 101 drug users were studied prospectively after cessation of IVDU. Of these, 75.8% were anti-HCV positive, and 71.4% had elevated levels of alanine aminotransferase. These levels decreased significantly within 1 month of IVDU cessation (p 0.02). Liver biopsies showed minimal or mild fibrosis in 32 (71%) of 45 subjects, and severe fibrosis in two (4.4%) subjects. Anti-HCV-positive intravenous drug users in this study presented with mild liver disease and variable stages of disease progression. Biochemical disease activity might be affected by IVDU.
引用
收藏
页码：768 / 770
页数：3
相关论文
共 50 条
  • [1] Hepatitis C virus genotypes among intravenous drug users in Italy
    Stroffolini, AE
    Fiume, A
    Fatale, G
    Regni, F
    Ciccozzi, M
    Marzolini, A
    Mele, A
    HEPATOLOGY RESEARCH, 1997, 9 (01) : 20 - 27
  • [2] Prevention of hepatitis C virus infection in drug users
    Schulte, B.
    Stoever, H.
    Leicht, A.
    Schnackenberg, K.
    Reimer, J.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2008, 51 (10) : 1210 - 1217
  • [3] Prevalence of hepatitis C infection among intravenous drug users in Shanghai
    Tao, Yan-Lin
    Tang, Yu-Fan
    Qiu, Jian-Ping
    Cai, Xiao-Feng
    Shen, Xiao-Ting
    Wang, Ya-Xin
    Zhao, Xue-Tao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (32) : 5320 - 5325
  • [4] Prevalence of hepatitis C infection among intravenous drug users in Shanghai
    Yan-Lin Tao
    Yu-Fan Tang
    Jian-Ping Qiu
    Xiao-Feng Cai
    Xiao-Ting Shen
    Ya-Xin Wang
    Xue-Tao Zhao
    World Journal of Gastroenterology, 2013, (32) : 5320 - 5325
  • [5] National guidelines for the management of hepatitis C virus infection in drug users in Slovenia
    Maticic, Mojca
    Kastelic, Andrej
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2009, 78 (10): : 529 - 539
  • [6] MOLECULAR EPIDEMIOLOGY OF HEPATITIS-C VIRUS-INFECTION AMONG INTRAVENOUS-DRUG-USERS
    SILINI, E
    BONO, F
    CIVIDINI, A
    CERINO, A
    MACCABRUNI, A
    TINELLI, C
    BRUNO, S
    BELLOBUONO, A
    MONDELLI, MU
    JOURNAL OF HEPATOLOGY, 1995, 22 (06): : 691 - 695
  • [7] HEPATITIS-C VIRUS-INFECTION IN ITALIAN INTRAVENOUS-DRUG-USERS - EPIDEMIOLOGIC AND CLINICAL ASPECTS
    GALEAZZI, B
    TUFANO, A
    BARBIERATO, E
    BORTOLOTTI, F
    LIVER, 1995, 15 (04): : 209 - 212
  • [8] Prävention der Hepatitis C bei DrogenkonsumentenPrevention of hepatitis C virus infection in drug users
    Bernd Schulte
    H. Stöver
    A. Leicht
    K. Schnackenberg
    J. Reimer
    Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2008, 51 : 1210 - 1217
  • [9] What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users?
    Leal, P
    Stein, K
    Rosenberg, W
    JOURNAL OF MEDICAL SCREENING, 1999, 6 (03) : 124 - 131
  • [10] High hepatitis C virus prevalence and incidence among Canadian intravenous drug users
    Roy, E.
    Alary, M.
    Morissette, C.
    Leclerc, P.
    Boudreau, J. -F.
    Parent, R.
    Rochefort, J.
    Claessens, C.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (01) : 23 - 27
12345